Inflammation Clinical Trial
Official title:
Effects of Corinthian Currant Supplementation on Redox Status, Inflammatory Markers, and Performance During Prolonged Exercise
Verified date | October 2017 |
Source | University of Thessaly |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of the present study is to investigate the effect of pre-exercise supplementation
of Corinthian currant on metabolism, performance and blood redox status during, and after an
acute bout of prolonged exercise.
Methods: Eleven healthy male adults (18 - 45y) performed an acute bout of prolonged cycling
in a crossover fashion. Each bout consisted of a 90 min constant-intensity (70 - 75% VO2max)
submaximal glycogen depletion trial, followed by a time trial (TT) to exhaustion (95%
VO2max), with a wash out period of 2 weeks between bouts. During each experimental condition
and 30 min prior to exercise, participants consumed an isocaloric (1.5 g CHO/kg body mass)
amount of randomly assigned Corinthian currants, glucose drink, or water. Blood was drawn at
baseline, 30 min after the supplement consumption (pre-exercise) and at 30, 60, 90 min of
submaximal trial, after TT, and 1 h after the end of exercise (post TT), for the assessment
of metabolic changes and redox status alterations.
Status | Completed |
Enrollment | 11 |
Est. completion date | September 15, 2017 |
Est. primary completion date | June 30, 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 45 Years |
Eligibility |
Inclusion Criteria: - Normal BMI (18.5 - 24.99),absence of lower-limb musculoskeletal injury, absence of any metabolic disease, no drug/supplement consumption, and aerobic fitness (VO2max = 40ml/kg/min at baseline testing). Exclusion Criteria: - Abnormal BMI (<18.5, =25), presence of lower-limb musculoskeletal injury, presence of any metabolic disease, no drug/supplement consumption, and aerobic fitness (VO2max < 40ml/kg/min at baseline testing). |
Country | Name | City | State |
---|---|---|---|
Greece | School of Physical Education and Sport Science, University of Thessaly | Trikala | Thessaly |
Lead Sponsor | Collaborator |
---|---|
University of Thessaly |
Greece,
Chiou A, Panagopoulou EA, Gatzali F, De Marchi S, Karathanos VT. Anthocyanins content and antioxidant capacity of Corinthian currants (Vitis vinifera L., var. Apyrena). Food Chem. 2014 Mar 1;146:157-65. doi: 10.1016/j.foodchem.2013.09.062. Epub 2013 Sep 1 — View Citation
Febbraio MA, Chiu A, Angus DJ, Arkinstall MJ, Hawley JA. Effects of carbohydrate ingestion before and during exercise on glucose kinetics and performance. J Appl Physiol (1985). 2000 Dec;89(6):2220-6. — View Citation
Jeukendrup AE, Killer SC. The myths surrounding pre-exercise carbohydrate feeding. Ann Nutr Metab. 2010;57 Suppl 2:18-25. doi: 10.1159/000322698. Epub 2011 Feb 22. Review. — View Citation
Too BW, Cicai S, Hockett KR, Applegate E, Davis BA, Casazza GA. Natural versus commercial carbohydrate supplementation and endurance running performance. J Int Soc Sports Nutr. 2012 Jun 15;9(1):27. doi: 10.1186/1550-2783-9-27. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Differences in time trial performance between conditions | Participants performed an exercise protocol on a cycloergometer (Cycloergometer, Monark 834, ERGOMED C, Sweeden) consisted of 90 min of cycling at 70% - 75% VO2max, followed by a time trial (TT) at 95% VO2max to exhaustion or until the participants could not maintain a pace above 60 rpm. Gas exchange was monitored for the first 15 min until the desired steady state is established (70% - 75% VO2max), and every 25 min for 5 min thereafter. | After the 90 min submaximal exercise trial | |
Primary | Differences in glucose concentration (GLU) between conditions | Blood GLU concentration was assessed as a marker of human metabolism. Blood GLU concentration was estimated in a Clinical Chemistry Analyzer Z 1145 (Zafiropoulos Diagnostica, Athens, Greece) with commercially available kits (Zafiropoulos, Athens, Greece). Each sample is analyzed in duplicates. | At baseline, pre-exercise, 30 min, 60 min, 90 min of submaximal exercise trial, after exhaustion, 1 h post exercise | |
Primary | Differences in lactate concentration (LA) between conditions | Blood LA concentration was assessed as a marker of human metabolism. Blood LA concentration was estimated in a Clinical Chemistry Analyzer Z 1145 (Zafiropoulos Diagnostica, Athens, Greece) with commercially available kits (Zafiropoulos, Athens, Greece). Each sample is analyzed in duplicates. | AAt baseline, pre-exercise, 30 min, 60 min, 90 min of submaximal exercise trial, after exhaustion, 1 h post exercise | |
Primary | Differences in oxygen consumption (VO2) during exercise between conditions | Cardiorespiratory changes were recorded throughout the entire exercise. Gas exchange was monitored using a gas analyzer (CareFusion, Viasis, Yorba Linda, USA). | During the first 15 min of submaximal exercise trial until the desired steady state of VO2 (70% - 75%) was established, and every 25 min for 5 min thereafter | |
Primary | Differences in carbon dioxide (CO2) during exercise between conditions | Cardiorespiratory changes were recorded throughout the entire exercise. Gas exchange was monitored using a gas analyzer (CareFusion, Viasis, Yorba Linda, USA). | During the first 15 min of submaximal exercise trial until the desired steady state of VO2 (70% - 75%) was established, and every 25 min for 5 min thereafter | |
Primary | Differences in respiratory quotient (RQ) during exercise between conditions | Cardiorespiratory changes were recorded throughout the entire exercise. Gas exchange was monitored using a gas analyzer (CareFusion, Viasis, Yorba Linda, USA). | During the first 15 min of submaximal exercise trial until the desired steady state of VO2 (70% - 75%) was established, and every 25 min for 5 min thereafter | |
Primary | Differences in ventilation (VE) during exercise between conditions | Cardiorespiratory changes were recorded throughout the entire exercise. Gas exchange was monitored using a gas analyzer (CareFusion, Viasis, Yorba Linda, USA). | During the first 15 min of submaximal exercise trial until the desired steady state of VO2 (70% - 75%) was established, and every 25 min for 5 min thereafter | |
Primary | Differences in charbohydrates oxidation during exercise between conditions | Cardiorespiratory changes were recorded throughout the entire exercise. Gas exchange was monitored using a gas analyzer (CareFusion, Viasis, Yorba Linda, USA). | During the first 15 min of submaximal exercise trial until the desired steady state of VO2 (70% - 75%) was established, and every 25 min for 5 min thereafter | |
Primary | Differences in fat oxidation changes during exercise between conditions | Cardiorespiratory changes were recorded throughout the entire exercise. Gas exchange was monitored using a gas analyzer (CareFusion, Viasis, Yorba Linda, USA). | During the first 15 min of submaximal exercise trial until the desired steady state of VO2 (70% - 75%) was established, and every 25 min for 5 min thereafter | |
Primary | Differences in complete blood count (CBC) due to exercise between conditions | Assessment of CBC was performed in an automated hematological analyzer (Mythic 18, Orphee SA, Geneva, Switzerland). | At baseline, pre-exercise, 30 min, 60 min, 90 min of submaximal exercise trial, after exhaustion, 1 h post exercise | |
Primary | Differences in reduced glutathione (GSH) (µmol/g Hb) due to exercise between conditions | GSH will be measured as a general index of oxidative stress. For GSH, 20 µL of erythrocyte lysate will be treated with 5% TCA mixed with 660 µL of 67 mM sodium potassium phosphate (pH 8.0) and 330 ?L of 1 mM 5,5-dithiobis-2 nitrobenzoate. The samples will be incubated in the dark at room temperature for 45 min, and the absorbance will be read at 412 nm. | At baseline, pre-exercise, 30 min, 60 min, 90 min of submaximal exercise trial, after exhaustion, 1 h post exercise | |
Primary | Differences in oxidized glutathione (GSSG) (µmol/g Hb) due to exercise between conditions | GSSG will be measured as a general index of oxidative stress. Blood collected will be treated with NEM. For the analysis, 50 µL of erythrocyte lysate will be treating with 5% TCA and neutralized up to pH 7.0-7.5. One microliter of 2-vinylpyridine will be added, and the samples will be incubated for 2 h. Sample will be treated with TCA and will be mixed with 600 µL of 143 mM sodium phosphate 100 ?L of 3 mM NADPH, 100 ?L of 10 mM 5,5-dithiobis-2-nitrobenzoate, and 194 µL of distilled water. After the addition of 1 µL of glutathione reductase, the change in absorbance at 412 nm will be read for 3 min. | At baseline, pre-exercise, 30 min, 60 min, 90 min of submaximal exercise trial, after exhaustion, 1 h post exercise | |
Primary | Differences in thiobarbituric acid-reactive substances, TBARS (µM) due to exercise between conditions | TBARS will be measured as an index of lipid peroxidation. For TBARS determination, 100 µL of plasma will be mixed with 500 ?L of 35% TCA and 500 µL of Tris-HCl (200 mM, pH 7.4) and will be incubated for 10 min at room temperature. One milliliter of 2 M Na2SO4 and 55 mM thiobarbituric acid solution will be added, and the samples will be incubated at 95O C for 45 min. The samples will be cooled on ice for 5 min and then will be vortexed after adding 1 mL of 70% TCA. The samples will be centrifuged at 15,000g for 3 min, and the absorbance of the supernatant will be read at 530 nm. | At baseline, pre-exercise, 30 min, 60 min, 90 min of submaximal exercise trial, after exhaustion, 1 h post exercise | |
Primary | Differences in protein carbonyls, (PC) (nmol/mg pr) due to exercise between conditions | Changes in Protein carbonyls, PC (nmol/mg pr) Carbonyls will be measured as an index of protein oxidation. Protein carbonyls will be determined adding 50 µL of 20% TCA to 50 µL of plasma. Samples will be incubated in the dark at room temperature for 1 hour. The supernatant will be discarded, and 1 mL of 10% TCA will be added. The supernatant will be discarded, and 1 mL of ethanol-ethyl acetate will be added and centrifuged. The supernatant will be discarded, and 1 mL of 5 M urea will be added, vortexed, and incubated at 37C for 15 min. The samples will be centrifuged at 15,000g for 3 min at 4C, and the absorbance will be read at 375 nm. | At baseline, pre-exercise, 30 min, 60 min, 90 min of submaximal exercise trial, after exhaustion, 1 h post exercise |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03995979 -
Inflammation and Protein Restriction
|
N/A | |
Completed |
NCT03255187 -
Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT03577223 -
Egg Effects on the Immunomodulatory Properties of HDL
|
N/A | |
Completed |
NCT04383561 -
Relationship Between LRG and Periodontal Disease
|
N/A | |
Active, not recruiting |
NCT03622632 -
Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
|
||
Completed |
NCT06216015 -
Exercise Training and Kidney Transplantation
|
N/A | |
Completed |
NCT04856748 -
Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
|
||
Completed |
NCT05529693 -
Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population
|
N/A | |
Recruiting |
NCT05670301 -
Flemish Joint Effort for Biomarker pRofiling in Inflammatory Systemic Diseases
|
N/A | |
Recruiting |
NCT05415397 -
Treating Immuno-metabolic Depression With Anti-inflammatory Drugs
|
Phase 3 | |
Recruiting |
NCT05775731 -
Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
|
||
Recruiting |
NCT04543877 -
WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study
|
Early Phase 1 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Completed |
NCT03429920 -
Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors
|
N/A | |
Completed |
NCT06065241 -
Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals.
|
N/A | |
Completed |
NCT05864352 -
The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health
|
||
Completed |
NCT03318731 -
Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males
|
N/A | |
Not yet recruiting |
NCT06134076 -
Comparing Effects of Fermented and Unfermented Pulses and Gut Microbiota
|
N/A | |
Not yet recruiting |
NCT06422494 -
The Role of the Adrenergic System in Hypoglycaemia Induced Inflammatory Response in People With Type 1 Diabetes and People Without Type 1 Diabetes-RAID-II
|
N/A |